FOR IMMEDIATE RELEASE: July 7, 2016 Ken Malone SilcsBio, LLC 410.929.2305 Ken.Malone@silcsbio.com SilcsBio, LLC Receives Phase II NIH SBIR Funding Baltimore, Maryland: SilcsBio, LLC announced today a $1.3 million funding award from the National Institute of Health to develop new computer aided drug design (CADD) software. CADD software enables pharmaceutical companies to […]
Check out this video to understand more about SilcsBio!
SilcsBio has exclusive rights to use U.S. and foreign patents pending by the University of Maryland, Baltimore. Patents include: U.S. Patent Application 13/265,568, titled “Method for binding site identification by molecular dynamics simulation (SILCS: Site Identification by Ligand Competitive Saturation),” published as US 2012/0053067.
SILCS: Site Identification by Ligand Competitive Saturation is a ligand or drug design program that calculates the probability that general classes or specific R-groups will bind to a target molecule. This allows a medicinal chemist to design molecules that have a higher probability of binding the target protein. This method was developed by Dr. Alex […]